- Filed
- Oct 2, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Oct 2, 2023 | 19.99M sh |
| Shares Diluted | Q2 2024 · Aug 31, 2023 | 19.99M sh |
| Shares Diluted | Q2 2024 · Aug 31, 2023 | 19.99M sh |
| Shares Diluted | Q2 2024 · Aug 31, 2022 | 19.99M sh |
| Shares Diluted | Q2 2024 · Aug 31, 2022 | 19.99M sh |
| Cash And Equivalents | Q2 2024 · Aug 31, 2023 | $2.5K |
| Cash And Equivalents | Q2 2024 · Feb 28, 2023 | $3.58K |
| Current Liabilities | Q2 2024 · Aug 31, 2023 | $1.27M |
| Current Liabilities | Q2 2024 · Feb 28, 2023 | $1.24M |
| Total Liabilities | Q2 2024 · Aug 31, 2023 | $1.27M |
| Total Liabilities | Q2 2024 · Feb 28, 2023 | $1.24M |
| Current Assets | Q2 2024 · Aug 31, 2023 | $6.06K |
| Current Assets | Q2 2024 · Feb 28, 2023 | $14.25K |
| Total Assets | Q2 2024 · Aug 31, 2023 | $6.06K |
| Total Assets | Q2 2024 · Feb 28, 2023 | $14.25K |
| Operating Cash Flow | Q2 2024 · Aug 31, 2022 | −$9.52K |
| Stockholders Equity | Q2 2024 · Aug 31, 2022 | −$1.2M |
| Stockholders Equity | Q2 2024 · May 31, 2022 | −$1.19M |
| Stockholders Equity restated | Q2 2024 · Feb 28, 2022 | −$1.17M |
| Sga Expense | Q2 2024 · Aug 31, 2022 | $14.1K |
| Sga Expense | Q2 2024 · Aug 31, 2022 | $32.02K |
| Net Income | Q2 2024 · Aug 31, 2022 | −$14.1K |
| Net Income | Q2 2024 · Aug 31, 2022 | −$32.02K |
| Operating Income | Q2 2024 · Aug 31, 2022 | −$14.1K |
| Operating Income | Q2 2024 · Aug 31, 2022 | −$32.02K |
| Cost Of Revenue | Q2 2024 · Aug 31, 2022 | $0 |
| Cost Of Revenue | Q2 2024 · Aug 31, 2022 | $0 |